This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 86811-58-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Hong Kong
Inquiry
86811-58-7 / N-[[4-chloro-3-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]carbamoyl]-2,6-difluorobenzamide
Standard CAS: 86811-58-7
Multi CAS: No
Basic Information
copy
CAS
86811-58-7 copy
Multi CAS
No copy
Molecular Formula
C20H10CL2F5N3O3 copy
Molecular Weight
506.200000 copy
Exact Mass
505.001937 copy
InChI
InChI=1S/C20H10Cl2F5N3O3/c21-11-5-4-10(29-19(32)30-17(31)16-13(23)2-1-3-14(16)24)7-15(11)33-18-12(22)6-9(8-28-18)20(25,26)27/h1-8H,(H2,29,30,31,32) copy
InChIKey
YOWNVPAUWYHLQX-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
33 copy
Aromatic heavy atom count
18 copy
Fraction Csp3
0.05 copy
Rotatable bonds
4 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
108.62 copy
TPSA
80.32 copy
LogP / Solubility
WLOGP
6.44 copy
MLOGP
5.7 copy
XLogP3
6.1 copy
Consensus LogP
6.08 copy
Log S (ESOL)
-7.18 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-8.36 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-8.78 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.24 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
Yes copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy